|
KIAA1107 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.779000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.637400E-01 |
| Normal-vs-Stage2 |
9.650600E-01 |
| Normal-vs-Stage3 |
6.225600E-02 |
| Normal-vs-Stage4 |
3.401000E-03 |
| Stage1-vs-Stage2 |
8.667800E-01 |
| Stage1-vs-Stage3 |
1.538070E-02 |
| Stage1-vs-Stage4 |
4.843300E-04 |
| Stage2-vs-Stage3 |
2.255600E-01 |
| Stage2-vs-Stage4 |
4.908400E-02 |
| Stage3-vs-Stage4 |
2.071200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.896200E-01 |
| Normal-vs-AfricanAmerican |
1.807910E-02 |
| Normal-vs-Asian |
2.575000E-01 |
| Caucasian-vs-AfricanAmerican |
4.217900E-02 |
| Caucasian-vs-Asian |
2.646200E-01 |
| AfricanAmerican-vs-Asian |
3.886100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.716760E-01 |
| Normal-vs-Female |
7.162800E-01 |
| Male-vs-Female |
2.709000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.068600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.793400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.273160E-01 |
| Normal-vs-Age(81-100Yrs) |
1.872410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.097000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.522200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.164600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.654220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.565600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.342400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.323900E-02 |
| Normal-vs-Grade 2 |
3.901800E-01 |
| Normal-vs-Grade 3 |
1.396770E-01 |
| Normal-vs-Grade 4 |
6.10030004288831E-09 |
| Grade 1-vs-Grade 2 |
2.007800E-01 |
| Grade 1-vs-Grade 3 |
1.076440E-02 |
| Grade 1-vs-Grade 4 |
8.196400E-04 |
| Grade 2-vs-Grade 3 |
8.523000E-03 |
| Grade 2-vs-Grade 4 |
1.84297022087776E-13 |
| Grade 3-vs-Grade 4 |
5.75399999869219E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.344200E-03 |
| Normal-vs-ccB subtype |
4.760200E-04 |
| ccA subtype-vs-ccB subtype |
1.37023725699237E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.076400E-01 |
| Normal-vs-N1 |
1.842470E-03 |
| N0-vs-N1 |
2.931800E-02 |
|
|
